124 related articles for article (PubMed ID: 19781899)
1. Safer glycemic control using isomaltulose-based enteral formula: a pilot randomized crossover trial.
Egi M; Toda Y; Katayama H; Yokoyama M; Morita K; Arai H; Yamatsuji T; Bailey M; Naomoto Y
J Crit Care; 2010 Mar; 25(1):90-6. PubMed ID: 19781899
[TBL] [Abstract][Full Text] [Related]
2. Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study.
Mesejo A; Montejo-González JC; Vaquerizo-Alonso C; Lobo-Tamer G; Zabarte-Martinez M; Herrero-Meseguer JI; Acosta-Escribano J; Blesa-Malpica A; Martinez-Lozano F
Crit Care; 2015 Nov; 19():390. PubMed ID: 26549276
[TBL] [Abstract][Full Text] [Related]
3. Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients.
Mesejo A; Acosta JA; Ortega C; Vila J; Fernández M; Ferreres J; Sanchis JC; López F
Clin Nutr; 2003 Jun; 22(3):295-305. PubMed ID: 12765670
[TBL] [Abstract][Full Text] [Related]
4. Transitional NPH insulin therapy for critically ill patients receiving continuous enteral nutrition and intravenous regular human insulin.
Dickerson RN; Wilson VC; Maish GO; Croce MA; Minard G; Brown RO
JPEN J Parenter Enteral Nutr; 2013 Jul; 37(4):506-16. PubMed ID: 22914894
[TBL] [Abstract][Full Text] [Related]
5. A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes.
Alish CJ; Garvey WT; Maki KC; Sacks GS; Hustead DS; Hegazi RA; Mustad VA
Diabetes Technol Ther; 2010 Jun; 12(6):419-25. PubMed ID: 20470226
[TBL] [Abstract][Full Text] [Related]
6. Glycemic Effects of a Low-Carbohydrate Enteral Formula Compared With an Enteral Formula of Standard Composition in Critically Ill Patients: An Open-Label Randomized Controlled Clinical Trial.
van Steen SC; Rijkenberg S; Sechterberger MK; DeVries JH; van der Voort PHJ
JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):1035-1045. PubMed ID: 30133840
[TBL] [Abstract][Full Text] [Related]
7. [The optimal blood glucose target in critically ill patient: comparison of two intensive insulin therapy protocols].
Raurell Torredà M; del Llano Serrano C; Almirall Solsona D; Catalan Ibars RM; Nicolás Arfelis JM
Med Clin (Barc); 2014 Mar; 142(5):192-9. PubMed ID: 23490488
[TBL] [Abstract][Full Text] [Related]
8. A pilot study of the SPRINT protocol for tight glycemic control in critically Ill patients.
Lonergan T; Compte AL; Willacy M; Chase JG; Shaw GM; Hann CE; Lotz T; Lin J; Wong XW
Diabetes Technol Ther; 2006 Aug; 8(4):449-62. PubMed ID: 16939370
[TBL] [Abstract][Full Text] [Related]
9. Slowly digestible carbohydrate sources can be used to attenuate the postprandial glycemic response to the ingestion of diabetes-specific enteral formulas.
Vanschoonbeek K; Lansink M; van Laere KM; Senden JM; Verdijk LB; van Loon LJ
Diabetes Educ; 2009; 35(4):631-40. PubMed ID: 19448045
[TBL] [Abstract][Full Text] [Related]
10. Safe and effective use of a glycemic control protocol for neonates in a cardiac ICU.
Hebson CL; Chanani NK; Rigby MR; Wolf MJ; Deshpande SR; Montegna LM; Maher KO
Pediatr Crit Care Med; 2013 Mar; 14(3):284-9. PubMed ID: 23392366
[TBL] [Abstract][Full Text] [Related]
11. Improved safety with intravenous insulin therapy for critically ill patients with renal failure.
Dickerson RN; Lynch AM; Maish GO; Croce MA; Minard G; Brown RO
Nutrition; 2014 May; 30(5):557-62. PubMed ID: 24296035
[TBL] [Abstract][Full Text] [Related]
12. Use of a Low-carbohydrate Enteral Nutrition Formula with Effective Inhibition of Hypoglycemia and Post-infusion Hyperglycemia in Non-diabetic Patients Fed via a Jejunostomy Tube.
Nishiwaki S; Fujimoto H; Kurobe T; Baba A; Iwashita M; Hatakeyama H; Hayashi T; Maeda T
Intern Med; 2020 Aug; 59(15):1803-1809. PubMed ID: 32461526
[TBL] [Abstract][Full Text] [Related]
13. Management of Hyperglycemia and Enteral Nutrition in the Hospitalized Patient.
Davidson P; Kwiatkowski CA; Wien M
Nutr Clin Pract; 2015 Oct; 30(5):652-9. PubMed ID: 26084507
[TBL] [Abstract][Full Text] [Related]
14. A carbohydrate-restrictive strategy is safer and as efficient as intensive insulin therapy in critically ill patients.
de Azevedo JR; de Araujo LO; da Silva WS; de Azevedo RP
J Crit Care; 2010 Mar; 25(1):84-9. PubMed ID: 19327317
[TBL] [Abstract][Full Text] [Related]
15. Dietary Management of Blood Glucose in Medical Critically Ill Overweight and Obese Patients: An Open-Label Randomized Trial.
Rice TW; Files DC; Morris PE; Bernard AC; Ziegler TR; Drover JW; Kress JP; Ham KR; Grathwohl DJ; Huhmann MB; Gautier JBO
JPEN J Parenter Enteral Nutr; 2019 May; 43(4):471-480. PubMed ID: 30260488
[TBL] [Abstract][Full Text] [Related]
16. Effect of published scientific evidence on glycemic control in adult intensive care units.
Niven DJ; Rubenfeld GD; Kramer AA; Stelfox HT
JAMA Intern Med; 2015 May; 175(5):801-9. PubMed ID: 25775163
[TBL] [Abstract][Full Text] [Related]
17. Strict glycemic targets need not be so strict: a more permissive glycemic range for critically ill children.
Ulate KP; Lima Falcao GC; Bielefeld MR; Morales JM; Rotta AT
Pediatrics; 2008 Oct; 122(4):e898-904. PubMed ID: 18779254
[TBL] [Abstract][Full Text] [Related]
18. Increased hypoglycemia associated with renal failure during continuous intravenous insulin infusion and specialized nutritional support.
Dickerson RN; Hamilton LA; Connor KA; Maish GO; Croce MA; Minard G; Brown RO
Nutrition; 2011; 27(7-8):766-72. PubMed ID: 20971617
[TBL] [Abstract][Full Text] [Related]
19. Near-normal glycemia for critically ill patients receiving nutrition support: fact or folly.
Reeds D
Curr Opin Gastroenterol; 2010 Mar; 26(2):152-5. PubMed ID: 20075724
[TBL] [Abstract][Full Text] [Related]
20. The optimal target for acute glycemic control in critically ill patients: a network meta-analysis.
Yatabe T; Inoue S; Sakaguchi M; Egi M
Intensive Care Med; 2017 Jan; 43(1):16-28. PubMed ID: 27686353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
